These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33530734)

  • 1. Barriers to Integrated Medication-Assisted Treatment for Rural Patients With Co-occurring Disorders: The Gap in Managing Addiction.
    Snell-Rood C; Pollini RA; Willging C
    Psychiatr Serv; 2021 Aug; 72(8):935-942. PubMed ID: 33530734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System-level factors shaping the implementation of "hub and spoke" systems to expand MOUD in rural areas.
    Snell-Rood C; Willging C; Showalter D; Peters H; Pollini RA
    Subst Abus; 2021; 42(4):716-725. PubMed ID: 33284083
    [No Abstract]   [Full Text] [Related]  

  • 4. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of the evaluation of the California Hub and Spoke Program.
    Darfler K; Sandoval J; Pearce Antonini V; Urada D
    J Subst Abuse Treat; 2020 Jan; 108():26-32. PubMed ID: 31400985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.
    Rawson RA; Rieckmann T; Cousins S; McCann M; Pearce R
    Prev Med; 2019 Nov; 128():105785. PubMed ID: 31362002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From policy to practice: Pilot program increases access to medication for opioid use disorder in rural Colorado.
    Sorrell TR; Weber M; Alvarez A; Beste N; Hollins U; Amura CR; Cook PF
    J Subst Abuse Treat; 2020 Jul; 114():108027. PubMed ID: 32527514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
    Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
    J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The who, the what, and the how: A description of strategies and lessons learned to expand access to medications for opioid use disorder in rural America.
    Cole ES; DiDomenico E; Green S; Heil SKR; Hilliard T; Mossburg SE; Sussman AL; Warwick J; Westfall JM; Zittleman L; Salvador JG
    Subst Abus; 2021; 42(2):123-129. PubMed ID: 33689594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert providers implement integrated and coordinated care in opioid use disorder treatment.
    Harris LM; Guerrero EG; Khachikian T; Serrett V; Marsh JC
    Int J Drug Policy; 2024 Oct; 132():104567. PubMed ID: 39241532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
    Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
    J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
    Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
    Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.
    Molfenter T; Sherbeck C; Zehner M; Quanbeck A; McCarty D; Kim JS; Starr S
    Subst Abuse Treat Prev Policy; 2015 Mar; 10():13. PubMed ID: 25884206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia.
    Staton M; Pike E; Tillson M; Lofwall MR
    J Community Psychol; 2024 Nov; 52(8):997-1014. PubMed ID: 36930568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding access to medication treatment for opioid use disorders: Findings from the Washington State hub and spoke effort.
    Stewart MT; Daily SM; Thomas CP; Panas L; Ritter G; Reif S
    Drug Alcohol Depend; 2024 Mar; 256():111125. PubMed ID: 38368666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review.
    Bommersbach T; Justen M; Bunting AM; Funaro MC; Winstanley EL; Joudrey PJ
    Int J Drug Policy; 2023 Feb; 112():103931. PubMed ID: 36563489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.
    Brunet N; Moore DT; Lendvai Wischik D; Mattocks KM; Rosen MI
    Subst Abus; 2022; 43(1):39-46. PubMed ID: 32078492
    [No Abstract]   [Full Text] [Related]  

  • 20. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder.
    Jones J; Tierney M; Jacobs G; Chien SY; Mallisham S
    J Addict Nurs; 2020; 31(4):261-268. PubMed ID: 33264198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.